Publication: 2289

Publication: 2289

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Eur J Cancer Care (Engl) vol 26 (2)

Year:: 2017
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 5

Parents:: None
Children:: None

Program:: CCP
Primary Committee:: Health Outcomes
Sec. Committees:: Onc Nursing

Pharmas:
Grants:: P50 CA108961, U10 CA031946, P30 CA008748, U10 CA180850, UG1 CA189823

Corr. Author:
Authors:: E.M.L. Smith H. Pang C. YE C. Cirrincione S. Fleishman E.D. Paskett T. Ahles L.R. Bressler N. Le-Lindqwister C.E. Fadul C. LoprinzI C.L. Shapiro

Networks:: HEARTLAND, LAPS-AL002, LAPS-MN026, LAPS-NC010, LAPS-NY016, LAPS-OH007, NY021, VA009

Study: CALGB-170601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Duloxetine, chemotherapy-induced peripheral neuropathy, pain, oxaliplatin